Cara Therapeutics, Inc. Company Profile

04:27 EDT 4th July 2015 | BioPortfolio


News Articles [21 Associated News Articles listed on BioPortfolio]

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q4 2014 Results - Earnings Call Transcript

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q1 2015 Results - Earnings Call Transcript

2015 Portraits of Courage Honorees: Glenn and Cara O’Neill

In a race against time, Glenn and Cara O’Neill have quarantined their family for nearly one year to try and save their daughter, Eliza. Eliza, 5, has Sanfilippo Syndrome, a rare degenerative disease...

Cara Therapeutics Reports First Quarter 2015 Financial Results

– End-of-Phase 2 Meeting With FDA Informs Phase 3 Clinical Development Program for Novel Kappa Opioid I.V. CR845 – – Conference Call Today at 4:30 p.m. ET – SHELTON, Conn., May 12, 2015...

Cara Therapeutics to Present at 3rd Conference on the Therapeutic Potential of Kappa Opioids

Company to present data from human abuse liability (HAL) study of I.V. CR845  SHELTON, Conn., April 15, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology compan...

Cara Therapeutics to Present at the 2015 International Conference on Opioids

SHELTON, Conn., June 5, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate p...

Cara Therapeutics to Webcast Presentation at 17th Annual BIO CEO & Investor Conference

SHELTON, Conn., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to allevia...

Cara Therapeutics to Webcast Presentation at 14th Annual Needham Healthcare Conference

SHELTON, Conn., April 7, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate ...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Protecting the 'Hood Against Tobacco

Among all racial/ethnic groups, African Americans have the greatest risk of becoming ill or dying from tobacco-related diseases. Because of this disproportionate disease burden, it is part...

Companies [4 Associated Companies listed on BioPortfolio]

CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...

Cara Therapeutics, Inc.

CARA THERAPEUTICS -- OU NAME

Instituto de Cirugía Maxilofacial e Implantología

Me es grato darles la bienvenida a la página web del INSTITUTO DE CIRUGIA MAXILOFACIAL E IMPLANTOLOGIA.El Instituto, fundado en Mayo del 2000, tiene como objetivo el tratamiento integral médico-quir...

More Information about "Cara Therapeutics, Inc." on BioPortfolio

We have published hundreds of Cara Therapeutics, Inc. news stories on BioPortfolio along with dozens of Cara Therapeutics, Inc. Clinical Trials and PubMed Articles about Cara Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cara Therapeutics, Inc. Companies in our database. You can also find out about relevant Cara Therapeutics, Inc. Drugs and Medications on this site too.


Advertisement
 
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record